Nigel’s research interests lie primarily in the control of emerging/re-emerging and transboundary viruses (pandemic/inter-pandemic influenza, MERS/SARS coronavirus, rabies/lyssavirus and Ebolavirus) for which he has pioneered the development and deployment of viral pseudotype-based serologic and pharmacologic assays. Nigel co-established the VPU in 2010 to act as an interface between academia, industry, animal and public health laboratories with the purpose of translating basic virus research into in vitro cell culture based assays that can be readily employed for the characterisation of vaccines, antivirals and therapeutic antibodies. Nigel is an advocate of using social media platforms and new Open Access/Open Data initiatives for the dissemination of VPU activities.
Well done!
